Braeburn Revenue and Competitors
Estimated Revenue & Valuation
- Braeburn's estimated annual revenue is currently $41.5M per year.
- Braeburn's estimated revenue per employee is $193,750
- Braeburn's total funding is $133M.
Employee Data
- Braeburn has 214 Employees.
- Braeburn grew their employee count by 161% last year.
Braeburn's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Sales | Reveal Email/Phone |
2 | VP Market Access | Reveal Email/Phone |
3 | General Counsel and Corporate Secretary | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Associate Director, Data Operations | Reveal Email/Phone |
8 | Director Field Medical Affairs | Reveal Email/Phone |
9 | Chief Commercial Officer | Reveal Email/Phone |
10 | Director, Human Resources | Reveal Email/Phone |
Braeburn Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $34640M | 131797 | 0% | $11.4M | $149.8B |
What Is Braeburn?
Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder. We are committed to advancing a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of addiction faced by patients, healthcare professionals, payers and society. Braeburn has one mission: to fight the opioid addiction epidemic. The work we are doing can make a difference in the lives of patients who often shoulder the burden of treatment themselves. We aim to reduce stigma by raising awareness that OUD is a chronic brain disease best treated by evidence-based medication-assisted treatment. We are dedicated to developing into a highly effective organization; and through collaboration and commitment we can execute on our mission. For more information about Braeburn, please visit www.braeburnrx.com.
keywords:N/A
$133M
Total Funding
214
Number of Employees
$41.5M
Revenue (est)
161%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Braeburn News
The course was designed by John Bredemus and opened in 1931. It was changed to BraeBurn in 1931, and Hall of Famer Jimmy Demaret worked as a...
NorthBridge Bermudagrass was installed along with a new irrigation system and upgraded drainage. BraeBurn has been an exciting project for us...
CCX, which acquired Braeburn in 1944 and operates under its name, filed for Chapter 11 bankruptcy in Delaware on Sunday. Chapter 11 allows a...
PLYMOUTH MEETING, Pa., June 26, 2021 /PRNewswire/ -- Braeburn announces that the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release weekly and monthly injection for subcutaneous (SC) use (CIII) for moderate to severe opioid use disorder was accepted by the U.S. Food and Dr ...
PLYMOUTH MEETING, Pa., June 15, 2021 /PRNewswire/ -- Braeburn announces that today the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release injection for subcutaneous (SC) use (CIII) for moderate to severe opioid use disorder was resubmitted to the U.S. Food and Drug Adminis ...
Other Companies in Plymouth Meeting
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $45.2M | 225 | N/A | N/A |
#2 | $67.1M | 226 | 6% | N/A |
#3 | $6.5M | 229 | -22% | $446.4M |
#4 | $69.2M | 233 | 4% | N/A |
#5 | $36.4M | 239 | 13% | $1.1B |